Skip to main contentSkip to navigationSkip to search


October 2021
UK, £100m - £500m

Liberty advises the management team of Sequence Care Group on their acquisition by Intriva Capital.

Sequence Care Group (“Sequence”), a leading provider of high-quality specialist care services that enable adults with complex learning disabilities to live richer, happier lives, has announced an investment from Intriva Capital, the independent alternative asset manager.

It was great having someone experienced supporting us who was as responsive and knowledgeable as Kevin.

Tony Hegarty
CEO of Sequence Care Group

Intriva will be backing Sequence’s ambition to deliver high-quality care outcomes for each individual and to serve more people as the business expands its footprint in the United Kingdom.

Sequence was founded in 2001 and provides supported living and residential care homes for adults with learning disabilities. The company employs more than 760 people, including experienced specialist teams comprised of occupational therapy, speech and language therapy, and positive behavioural support workers. Sequence works in close partnership with Local Authorities and the NHS to deliver market-leading care quality, with 97% of its facilities currently rated good or outstanding by the Care Quality Commission (CQC).

With Intriva’s support, Sequence will be able to expand its care services and footprint through developing new homes designed around the needs of individuals with learning disabilities and those with additional needs, such as a physical disability. Sequence will also look to bring on more like-minded high-quality providers across the United Kingdom. As it grows the company, it will continue to build on its operational excellence and care quality, with the aim of setting the industry standard for supported living and residential care homes.

It was a pleasure working with Tony and the team on this important milestone in their careers, and we wish them well in this new cycle of growth for the company.

Kevin Palmer
+44 (0) 7841 468 261